Hamad Medical Corporation clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Minor: LD - Learning · Development, Validation and Testing of an Education Program for Identification of Learning Disabilities Among School Children by Primary School Teachers in Qatar Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Notable: MESI-HM · Middle East Study of Infections · Hematological Malignancies Primary endpoint(s) modified
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-02 | NCT07908693 A Novel Treatment for Chronic Low Back Pain Using Multi Angular Isometric Lumbar… | Recruiting | |
| 2026-10-28 | NCT07900542 Middle East Study of Infections in Patients With Hematological Malignancies | Recruiting |
Active trials by phase
| Phase 4 | 1 |
Not charted: 16 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Diabetes (2) · Heart Disease (2) · Stroke (2) · Chronic Kidney Disease (1)
Get alerts when Hamad Medical Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.